An Investigator- And Subjects- Blind Phase 1 Study To Investigate Pharmacokinetics, Safety And Tolerability Of Sitaxentan In Japanese Healthy Subjects Following Single And Multiple Doses And Western Healthy Subjects Following Single Dose.
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2010
At a glance
- Drugs Sitaxentan (Primary)
- Indications Coronary disorders; Heart failure
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 05 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Sep 2009 New trial record